PAUL A. MIEYAL, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

CAPRICOR THERAPEUTICS, INC.

Filing Date Source Excerpt
2008-04-18 Dr. Mieyal received his Ph.D. in Pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.
2009-11-02 Dr. Mieyal received his Ph.D. in Pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.
2010-06-15 Dr. Mieyal received his Ph.D. in Pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.
2011-04-08 Dr. Mieyal received his Ph.D. in Pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.
2013-10-10 Paul Mieyal, Ph.D., CFA has served as a director of Nile since September 2007... Dr. Mieyal received his Ph.D. in Pharmacology from New York Medical College, a B.A. in chemistry and psychology from Case Western Reserve University, and is a Chartered Financial Analyst.

Data sourced from SEC filings. Last updated: 2026-02-03